Comparison of risk classification between endopredict and mammaprint in er-positive/her2-negative primary invasive breast cancer

HIGHLIGHTS

• who: Alberto Pel#_#x00E1 and collaborators from the Spain, Faculty of Medicine, Universidad Autou0301noma de, Spain, Translational Oncology have published the Article: Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0183452]. September 8, 2017 of March/30,/2017
• what: The aim of this study was to compare retrospectively the concordance in risk classification between the EndoPredict and the MammaPrint tests in 40 ER+/HER2- breast carcinomas. Interestingly, the study shows that despite the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.